Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study [Expression of concern] [Erratum]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234872/
https://www.ncbi.nlm.nih.gov/pubmed/32494156
http://dx.doi.org/10.2147/OTT.S260688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234872/
https://www.ncbi.nlm.nih.gov/pubmed/32494156
http://dx.doi.org/10.2147/OTT.S260688

Ejemplares similares